IDT Biologika moves into spotlight as Germany eyes Sputnik V vaccine | Business| Economy and finance news from a German perspective | DW
IDT Biologika moves into spotlight as Germany eyes Sputnik V vaccine The eastern German firm is raising hopes amid the EU's troubled vaccination drive, after Russia reportedly weighs producing its Sputnik V vaccine there. But despite promises of state support, IDT remains cautious. Dessau-based IDT Biologika is reported to be in talks with Russia over the production of the Sputnik V vaccine While Health Minister Jens Spahn said on Wednesday that talks were being held with Moscow to explore production capacities for the Russian jab in Germany, a regional leader confirmed one day later that t...